WallStreetZenWallStreetZen

NASDAQ: VYNE
Vyne Therapeutics Inc Stock Ownership - Who owns Vyne Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vyne Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Tyler ZerondaCHIEF FINANCIAL OFFICER2025-06-303,420$1.65
$5.64kSell
David DomzalskiPRESIDENT AND CEO2025-06-3012,676$1.65
$20.92kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2025-06-303,581$1.65
$5.91kSell
Iain StuartCHIEF SCIENTIFIC OFFICER2025-06-302,453$1.65
$4.05kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2025-06-021,145$0.81
$927.45Buy
David DomzalskiPRESIDENT AND CEO2025-06-028,681$0.81
$7.03kBuy
David DomzalskiPRESIDENT AND CEO2025-03-3130,498$1.58
$48.19kSell
Mutya HarschCHIEF LEGAL OFFICER AND GC2025-03-318,828$1.58
$13.95kSell
Tyler ZerondaCHIEF FINANCIAL OFFICER2025-03-318,399$1.58
$13.27kSell
Iain StuartCHIEF SCIENTIFIC OFFICER2025-03-316,044$1.58
$9.55kSell

1 of 2

VYNE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VYNE insiders and whales buy or sell their stock.

VYNE Shareholders

What type of owners hold Vyne Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC29.61%4,935,057$7.11MInsider
Albert Cha24.07%4,011,236$5.78MInsider
Vivo Capital VIII LLC24.07%4,011,236$5.78MInsider
Remeditex Ventures LLC16.57%2,761,663$3.98MInsider
Presidio Partners 2007 GP LP15.65%2,608,540$3.76MInsider
Venbio Global Strategic Fund II LP8.77%1,461,552$2.10MInsider
Eventide Asset Management LLC8.37%1,394,336$2.01MInstitution
Merck Co Inc7.46%1,243,168$1.79MInsider
Fmr LLC6.71%1,118,054$1.61MInsider
Ai Biotechnology LLC6.70%1,116,585$1.61MInsider

1 of 3

VYNE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VYNE21.54%78.46%Net SellingNet Selling
MBIO2.60%16.34%Net Selling
SLXN3.95%96.05%
GNPX1.38%18.31%Net SellingNet Selling
ADXN0.01%0.00%
View Top Biotech Stocks

Vyne Therapeutics Stock Ownership FAQ

Who owns Vyne Therapeutics?

Vyne Therapeutics (NASDAQ: VYNE) is owned by 42.98% institutional shareholders, 156.50% Vyne Therapeutics insiders, and 0.00% retail investors. Perceptive Advisors LLC is the largest individual Vyne Therapeutics shareholder, owning 4.94M shares representing 29.61% of the company. Perceptive Advisors LLC's Vyne Therapeutics shares are currently valued at $1.96M.

If you're new to stock investing, here's how to buy Vyne Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.